SCHEMBL5962279

SCHEMBL5962279

CC(C)NP(C)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3486881 0.78
SCHEMBL18279841 0.78 ALDH1A1 (0.48)
Hydrochloric Acid SCHEMBL11815969 0.75 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL28132101 0.75
SCHEMBL4336527 0.73
SCHEMBL739862 0.73 ALDH1A1 (0.43)
SCHEMBL2179943 0.73
SCHEMBL16575627 0.73 GGH (0.48)
SCHEMBL16575618 0.73 GGH (0.48)
SCHEMBL16575628 0.73 GGH (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507530-B2 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same EISAI R&D MANAGEMENT CO., LTD. (JP) 2013-08-13 US disclosed
US-8178579-B2 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-15 US disclosed
US-20100129349-A1 Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus HEINRICHS DAVID E 2010-05-27 US disclosed
US-7700577-B2 Carbohydrate based anti-bacterials ALCHEMIA LIMITED (AU) 2010-04-20 US disclosed
US-20090082403-A1 PYRIDINE DERIVATIVES SUBSTITUTED BY HETEROCYCLIC RING AND PHOSPHONOAMINO GROUP, AND ANTI-FUNGAL AGENT CONTAINING SAME EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-03-26 US disclosed
US-20080269245-A1 Dioxanes and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2008-10-30 US disclosed
US-7235244-B2 Compositions and methods for treating papillomavirus-infected cells PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-06-26 US disclosed